financetom
Business
financetom
/
Business
/
Snack Giant Kellanova Soars Over 5% On Strong Q2 Results And Upgraded FY24 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Snack Giant Kellanova Soars Over 5% On Strong Q2 Results And Upgraded FY24 Guidance
Aug 1, 2024 7:13 AM

Kellanova ( K ) reported second-quarter results, with adjusted EPS and sales exceeding expectations despite external challenges.

The company reported adjusted earnings per share of $1.01, beating the analyst consensus of 90 cents.

Quarterly sales of $3.192 billion (down 4.7%) beat the street view of $3.150 billion.

Despite negative impacts from adverse currency translation and the 2023 divestiture of its Russian business, the company’s organic growth stayed within its long-term target range.

The company said it achieved double-digit growth in operating profit and EPS, reflecting faster-than-expected margin improvements.

Also Read: Bitcoin, Ethereum, Dogecoin Slip Amid Flare-Up Of Iran-Israel Tensions: Analyst Says ‘A Big Move Is Coming Soon’ For King Crypto

“Our top-line growth featured a return to volume growth in two of our Regions, and improvements in other markets, led by our biggest brand Pringles,” commented Steve Cahillane, Kellanova’s Chairman, President and Chief Executive Officer.

Adjusted operating profit in the quarter under review grew 13.3% to $502 million.

“This was supported by fully restored commercial activity, including a double-digit increase in brand building investment while still improving profit margins,” Cahillane added.

Outlook: Kellanova ( K ) has increased its FY24 guidance, raising its organic basis net sales growth forecast to 3.5% or better, from its previous guidance of approximately 3% or better. The company also raised its adjusted EPS guidance from $3.55-$3.65 to $3.65-$3.75 against the consensus of $3.62.

Price Action: K shares are trading higher by 5.16% to $61.15 at last check Thursday.

Read Next:   

Trump Launches Limited Edition Bitcoin-Themed Sneakers Following Bitcoin 2024 Keynote: Report

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Commerzbank on Overnight News
Commerzbank on Overnight News
Mar 7, 2025
06:26 AM EST, 03/07/2025 (MT Newswires) -- Commerzbank in its European Sunrise note of Friday highlighted: Markets: United States Treasuries rise into New York close, stay bid in Asia. U.S. equities close lower, Asian equities mixed. EUR trades above $1.08, Brent hovers around $69.5/barrel. Fed: Federal Reserve Governor Christopher Waller says there is nothing wrong with forecast of two rate...
Trump Delays Tariffs on Certain Canadian, Mexican Imports
Trump Delays Tariffs on Certain Canadian, Mexican Imports
Mar 7, 2025
06:32 AM EST, 03/07/2025 (MT Newswires) -- US President Donald Trump has issued temporary tariff exemptions for various goods coming into the US from Mexico and Canada, partially reversing his recent 25% duties on those two countries, media outlets reported. The exemptions will apply to goods that are in compliance with a North American trade pact, CNBC reported, citing a...
Market Chatter: Paramount Global's Sale to Skydance Media May be Blocked by Delaware Judge
Market Chatter: Paramount Global's Sale to Skydance Media May be Blocked by Delaware Judge
Mar 7, 2025
06:35 AM EST, 03/07/2025 (MT Newswires) -- Paramount Global ( PARAA ) 's $8 billion sale to Skydance Media could be blocked from closing after a Delaware judge agreed to consider a class action lawsuit alleging that the sale short-changes public shareholders, Reuters reported Thursday citing a court filing. Pension funds for New York City employees that own Paramount stock...
Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta
Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta
Mar 7, 2025
06:33 AM EST, 03/07/2025 (MT Newswires) -- Anika Therapeutics ( ANIK ) said Friday it completed the all-cash sale of its Parcus Medical business to Medacta. Financial terms were not disclosed. Anika President and Chief Executive Cheryl R. Blanchard said the sale allows the company to focus on its core hyaluronic acid technology. Anika said it has agreed to work...
Copyright 2023-2026 - www.financetom.com All Rights Reserved